Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.24
(
1.56%
)
Bitcoin
71,170.93
(
-0.10%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: microcapfun post# 71778

Monday, 01/19/2009 7:40:34 PM

Monday, January 19, 2009 7:40:34 PM

Post# of 257257
Re: HGSI / Albuferon monthly dosing

Are the PK calculations you posted for genotype-2/3 patients, specifically? The numbers for genotype-2/3 might be different from genotype-1, and this could explain why NVS/HGSI are pursuing monthly dosing for genotype-2/3 only.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now